栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/03/16 | 1,561 | 1,595 | 1,561 | 1,594 | +1 | +0.1% | 102,100 |
| 2023/03/15 | 1,597 | 1,600 | 1,587 | 1,593 | +10 | +0.6% | 84,200 |
| 2023/03/14 | 1,583 | 1,594 | 1,566 | 1,583 | -18 | -1.1% | 129,400 |
| 2023/03/13 | 1,608 | 1,610 | 1,594 | 1,601 | -24 | -1.5% | 65,400 |
| 2023/03/10 | 1,617 | 1,634 | 1,615 | 1,625 | -11 | -0.7% | 93,100 |
| 2023/03/09 | 1,625 | 1,636 | 1,617 | 1,636 | +20 | +1.2% | 83,100 |
| 2023/03/08 | 1,620 | 1,627 | 1,615 | 1,616 | -7 | -0.4% | 107,100 |
| 2023/03/07 | 1,610 | 1,631 | 1,608 | 1,623 | +18 | +1.1% | 114,100 |
| 2023/03/06 | 1,598 | 1,606 | 1,589 | 1,605 | +16 | +1% | 107,000 |
| 2023/03/03 | 1,591 | 1,591 | 1,577 | 1,589 | +10 | +0.6% | 94,400 |
| 2023/03/02 | 1,576 | 1,589 | 1,571 | 1,579 | +5 | +0.3% | 83,700 |
| 2023/03/01 | 1,563 | 1,574 | 1,563 | 1,574 | +13 | +0.8% | 103,100 |
| 2023/02/28 | 1,571 | 1,574 | 1,560 | 1,561 | -1 | -0.1% | 99,300 |
| 2023/02/27 | 1,570 | 1,574 | 1,559 | 1,562 | -7 | -0.4% | 36,000 |
| 2023/02/24 | 1,558 | 1,573 | 1,550 | 1,569 | +9 | +0.6% | 86,300 |
| 2023/02/22 | 1,560 | 1,567 | 1,552 | 1,560 | -9 | -0.6% | 113,500 |
| 2023/02/21 | 1,566 | 1,576 | 1,564 | 1,569 | +3 | +0.2% | 71,700 |
| 2023/02/20 | 1,563 | 1,577 | 1,563 | 1,566 | +3 | +0.2% | 40,500 |
| 2023/02/17 | 1,562 | 1,571 | 1,560 | 1,563 | -8 | -0.5% | 62,800 |
| 2023/02/16 | 1,575 | 1,580 | 1,570 | 1,571 | +9 | +0.6% | 42,600 |
| 2023/02/15 | 1,568 | 1,573 | 1,556 | 1,562 | -3 | -0.2% | 87,900 |
| 2023/02/14 | 1,579 | 1,589 | 1,559 | 1,565 | +7 | +0.4% | 56,900 |
| 2023/02/13 | 1,565 | 1,567 | 1,545 | 1,558 | -1 | -0.1% | 71,400 |
| 2023/02/10 | 1,566 | 1,579 | 1,557 | 1,559 | -18 | -1.1% | 80,300 |
| 2023/02/09 | 1,559 | 1,577 | 1,554 | 1,577 | +9 | +0.6% | 70,100 |
| 2023/02/08 | 1,576 | 1,576 | 1,562 | 1,568 | +10 | +0.6% | 72,800 |
| 2023/02/07 | 1,571 | 1,572 | 1,556 | 1,558 | -18 | -1.1% | 87,700 |
| 2023/02/06 | 1,600 | 1,600 | 1,575 | 1,576 | -9 | -0.6% | 79,900 |
| 2023/02/03 | 1,581 | 1,585 | 1,573 | 1,585 | -4 | -0.3% | 114,900 |
| 2023/02/02 | 1,607 | 1,607 | 1,580 | 1,589 | -19 | -1.2% | 201,400 |
| 2023/02/01 | 1,600 | 1,614 | 1,582 | 1,608 | +20 | +1.3% | 199,600 |
| 2023/01/31 | 1,602 | 1,615 | 1,581 | 1,588 | -44 | -2.7% | 335,700 |
| 2023/01/30 | 1,650 | 1,657 | 1,630 | 1,632 | -10 | -0.6% | 189,800 |
| 2023/01/27 | 1,670 | 1,673 | 1,635 | 1,642 | -25 | -1.5% | 144,500 |
| 2023/01/26 | 1,668 | 1,668 | 1,653 | 1,667 | +9 | +0.5% | 135,200 |
| 2023/01/25 | 1,653 | 1,669 | 1,642 | 1,658 | +6 | +0.4% | 133,500 |
| 2023/01/24 | 1,632 | 1,654 | 1,621 | 1,652 | +28 | +1.7% | 115,100 |
| 2023/01/23 | 1,619 | 1,624 | 1,603 | 1,624 | +25 | +1.6% | 102,300 |
| 2023/01/20 | 1,609 | 1,609 | 1,592 | 1,599 | -7 | -0.4% | 127,800 |
| 2023/01/19 | 1,613 | 1,618 | 1,595 | 1,606 | -14 | -0.9% | 164,700 |
| 2023/01/18 | 1,585 | 1,620 | 1,585 | 1,620 | +43 | +2.7% | 109,500 |
| 2023/01/17 | 1,590 | 1,594 | 1,566 | 1,577 | -12 | -0.8% | 170,000 |
| 2023/01/16 | 1,598 | 1,603 | 1,581 | 1,589 | -27 | -1.7% | 145,100 |
| 2023/01/13 | 1,636 | 1,643 | 1,610 | 1,616 | -26 | -1.6% | 113,300 |
| 2023/01/12 | 1,643 | 1,657 | 1,626 | 1,642 | -1 | -0.1% | 125,300 |
| 2023/01/11 | 1,623 | 1,657 | 1,622 | 1,643 | +23 | +1.4% | 155,000 |
| 2023/01/10 | 1,638 | 1,646 | 1,618 | 1,620 | -22 | -1.3% | 91,800 |
| 2023/01/06 | 1,635 | 1,644 | 1,625 | 1,642 | +11 | +0.7% | 79,000 |
| 2023/01/05 | 1,638 | 1,640 | 1,613 | 1,631 | -25 | -1.5% | 113,100 |
| 2023/01/04 | 1,704 | 1,704 | 1,654 | 1,656 | -53 | -3.1% | 117,300 |
401～
450
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 235,300円 | +7.6% | +57.5% | 2.25% | 18.19倍 | 1.78倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 121,600円 | +197.7% | - | 0.00% | 49.69倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 66,000円 | -3.7% | -36.7% | 3.03% | 22.39倍 | 1.47倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 101,200円 | - | - | 0.00% | - | 50.96倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
